These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2323521

  • 1. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
    Malesci A, De Fazio C, Festorazzi S, Bonato C, Valentini A, Tacconi M, Rovati L, Setnikar I.
    Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521
    [Abstract] [Full Text] [Related]

  • 2. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
    Corazziari E, Ricci R, Biliotti D, Bontempo I, De Medici A, Pallotta N, Torsoli A.
    Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
    [Abstract] [Full Text] [Related]

  • 3. Effects of loxiglumide on gallbladder emptying in healthy volunteers.
    Niederau C, Heintges T, Rovati L, Strohmeyer G.
    Gastroenterology; 1989 Nov; 97(5):1331-6. PubMed ID: 2792664
    [Abstract] [Full Text] [Related]

  • 4. Effect of a cholecystokinin receptor antagonist (loxiglumide) on gallbladder contractile function in guinea pigs.
    Tsubo K, Arai M, Omachi H, Mitamura K.
    J Gastroenterol; 1996 Aug; 31(4):578-81. PubMed ID: 8844481
    [Abstract] [Full Text] [Related]

  • 5. Dose-response effects of oral loxiglumide on postprandial gall-bladder emptying in man.
    Malesci A, De Fazio C, Festorazzi S, Bonato C, Valentini A, Tacconi M, Bekkering M, Giacovelli G, D'Amato M, Rovati LC.
    Arzneimittelforschung; 1992 Nov; 42(11):1359-62. PubMed ID: 1492852
    [Abstract] [Full Text] [Related]

  • 6. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
    Konturek JW, Konturek SJ, Kurek A, Bogdal J, Oleksy J, Rovati L.
    Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511
    [Abstract] [Full Text] [Related]

  • 7. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs.
    Niederau C, Karaus M.
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G315-24. PubMed ID: 1996649
    [Abstract] [Full Text] [Related]

  • 8. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA, de Boer SY, Lam WF, Rovati LC, Lamers CB, Masclee AA.
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE, Creutzfeldt W, Höcker M, Choudhury AR, Nustede R, Schleser A, Nitsche R, Rovati LC, Schafmayer A, Fölsch UR.
    Digestion; 1990 Dec; 46 Suppl 2():232-9. PubMed ID: 2262057
    [Abstract] [Full Text] [Related]

  • 11. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome.
    Niederau C, Faber S, Karaus M.
    Gastroenterology; 1992 Jun; 102(6):1889-98. PubMed ID: 1587408
    [Abstract] [Full Text] [Related]

  • 12. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K, Saito T, Saeki M, Ninomiya K, Kasai H, Kimura K, Fujii M.
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [Abstract] [Full Text] [Related]

  • 13. In vivo comparison of inhibition with proglumide and CR-1409 of cholecystokinin-induced pressure in the biliary tract of the guinea pig.
    Poston GJ, MacLellan DG, Hashimoto T, Upp JR, Townsend CM, Thompson JC.
    Surg Gynecol Obstet; 1990 Mar; 170(3):217-22. PubMed ID: 2305348
    [Abstract] [Full Text] [Related]

  • 14. Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers.
    Schwarzendrube J, Niederau M, Lüthen R, Niederau C.
    Gastroenterology; 1991 Jun; 100(6):1683-90. PubMed ID: 2019374
    [Abstract] [Full Text] [Related]

  • 15. Effects of somatostatin and loxiglumide on gallbladder motility.
    Lieverse RJ, Jansen JB, Jebbink MC, Masclee AA, Rovati LC, Lamers CB.
    Eur J Clin Pharmacol; 1995 Jun; 47(6):489-92. PubMed ID: 7768249
    [Abstract] [Full Text] [Related]

  • 16. Cholecystokinin in the control of gastric acid secretion in humans.
    Konturek JW, Gutwinska-Konturek M, Gabryelewicz A, Konturek SJ, Domschke W.
    J Clin Gastroenterol; 1993 Jun; 17 Suppl 1():S40-5. PubMed ID: 7904286
    [Abstract] [Full Text] [Related]

  • 17. Duration and potency of anticholecystokinin action of subcutaneous and oral loxiglumide on cerulein-stimulated pancreatic exocrine secretion.
    Watanabe N, Otsuki M.
    Int J Pancreatol; 1993 Apr; 13(2):129-37. PubMed ID: 8501354
    [Abstract] [Full Text] [Related]

  • 18. [The kinetics of canine gallbladder before and after feeding and cerulein administration].
    Romański K, Sławuta P.
    Folia Med Cracov; 2003 Apr; 44(1-2):129-38. PubMed ID: 15232894
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers.
    Niederau C, Schwarzendrube J, Lüthen R, Niederau M, Strohmeyer G, Rovati L.
    Pancreas; 1992 Apr; 7(1):1-10. PubMed ID: 1557335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.